Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Alnylam amyloidosis drug led to “small” benefits: FDA Markets September 11, 2023 Grandbrothers The U.S. Meals and Drug Administration (FDA) mentioned Monday that patisiran, a RNAi therapeutic developed by Alnylam Prescribed drugs…
